The evidence balance on compounded GLP-1 safety The National Center for Complementary and Integrative Health (NCCIH), the FDA, and multiple medical societies - including the American Diabetes Association - have published guidance noting that compounded GLP-1 preparations carry additional safety uncertainty compared to FDA-approved finished products
Heat may affect the patchs performance
Midsection transformation The abdominal area undergoes the most medically significant transformation during GLP-1 therapy
Allen Cunningham, Co-Founder & Chief Operating Officer
[DOI] [PubMed] [Google Scholar] 193.Richards P, Parker HE, Adriaenssens AE, Hodgson JM, Cork SC, Trapp S, Gribble FM, Reimann F